Association of SLCO2B1 Genotypes With Time to Progression and Overall Survival in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer

PURPOSE: To validate the association of three previously demonstrated SLCO2B1 germline variants with time to progression (TTP) in patients receiving androgen-deprivation therapy (ADT), and to evaluate if the SLCO2B1 genetic variants impacted overall survival (OS) for prostate cancer (PC). PATIENTS A...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Wang, Xiaodong, Harshman, Lauren C., Xie, Wanling, Nakabayashi, Mari, Qu, Fangfang, Pomerantz, Mark M., Lee, Gwo-Shu Mary, Kantoff, Philip W.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2016
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872031/
https://ncbi.nlm.nih.gov/pubmed/26668348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.62.5988
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky